1. |
Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma[J]. Semin Liver Dis, 2005, 25(2):181-200.
|
2. |
丛文铭, 吴孟超. 肝癌术后复发发生机制及临床病理学意义[J]. 中国实用外科杂志, 2012, 32(10):809-811.
|
3. |
Kim MY, Oskarsson T, Acharyya S, et al. Tumor self-seeding by circulating cancer cells[J]. Cell, 2009, 139(7):1315-1326.
|
4. |
Zhang Y, Li J, Cao L, et al. Circulating tumor cells in hepatocellular carcinoma:detection techniques, clinical implications, and future perspectives[J]. Semin Oncol, 2012, 39(4):449-460.
|
5. |
Portolani N, Coniglio A, Ghidoni S, et al. Early and late recurrence after liver resection for hepatocellular carcinoma:prognosticand therapeutic implications[J]. Ann Surg, 2006, 243(2):229-235.
|
6. |
孙建, 简志祥, 区应亮, 等. 肝癌根治性切除术后早期复发时限和模式的确定及其对预后的影响[J]. 实用医学杂志, 2011, 27(10):1748-1750.
|
7. |
Poon RT, Fan ST, Ng IO, et al. Significance of resection marginin hepatectomy for hepatocellular carcinoma:A critical reappraisal[J]. Ann Surg, 2000, 231(4):544-551.
|
8. |
Kow AW, Kwon CH, Song S, et al. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma:review of 1 222 cases of hepatectomy in a tertiary institution[J]. Ann Surg Oncol, 2012, 19(7):2246-2255.
|
9. |
Burak KW. Prognosis in the early stages of hepatocellular carci-noma:Predicting outcomes and properly selecting patients forcurative options[J]. Can J Gastroenterol, 2011, 25(9):482-484.
|
10. |
Wu TH, Yu MC, Chen TC, et al. Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma[J]. J Surg Oncol, 2012, 105(1):85-90.
|
11. |
Lee CW, Chan KM, Lee CF, et al. Hepatic resection for hepatocellular carcinoma with lymph node metastasis:clinicopathological analysis and survival outcome[J]. Asian J Surg, 2011, 34(2):53-62.
|
12. |
Ye JZ, Miao ZG, Wu FX, et al. Recurrence after anatomicresection versus nonanatomic resection for hepatocellular carcinoma:a meta-analysis[J]. Asian Pac J Cancer Prev, 2012, 13(5):1771-1777.
|
13. |
Poon RT, Fan ST, Lo CM, et al. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitisB-related cirrhosis[J]. J Clin Oncol, 2000, 18(5):1094-1101.
|
14. |
Tamura Y, Suda T, Arii S, et al. Value of highly sensitive fucos-ylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment[J]. Dig Dis Sci, 2013 Apr 18. [Epub ahead of print].
|
15. |
Shirakawa H, Suzuki H, Shimomura M, et al. Glypican-3 expre-ssion is correlated with poor prognosis in hepatocellular carcinoma[J]. Cancer Sci, 2009, 100(8):1403-1407.
|
16. |
Chen IP, Ariizumi SI, Nakano M, et al. Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy[J]. J Gastroenterol, 2013 Mar 27. [Epub ahead of print].
|
17. |
Ahn S, Hyeon J, Park CK. Metadherin is a prognostic predictor of hepatocellular carcinoma after curative hepatectomy[J]. Gut Liver, 2013, 7(2):206-212.
|
18. |
Hyeon J, Ahn S, Lee JJ, et al. Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma[J]. Dig Dis Sci, 2013 Mar 2. [Epub ahead of print].
|
19. |
Zhong JH, Li LQ. Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma:A meta-analysis[J]. Hepatol Res, 2010, 40(10):943-953.
|
20. |
Peng BG, He Q, Li JP, et al. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus[J]. Am J Surg, 2009, 198(3):313-318.
|
21. |
Nitta H, Beppu T, Imai K, et al. Adjuvant hepatic arterial infusionchemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion[J]. World J Surg, 2013, 37(5):1034-1042.
|
22. |
廖锦岐, 袁波, 程玉, 等. 不同治疗方法对肝癌术后复发的评价[J]. 中国医药科学, 2011, 19(1):46-47.
|
23. |
Lau WY, Lai EC. Hepatocellular carcinoma:current management and recent advances[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(3):237-257.
|
24. |
Zhou YM, Sui CG, Li B, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma:a local experience and a systematic review[J]. World J Surg Oncol, 2010, 8:55.
|
25. |
Chan DL, Morris DL, Chua TC. Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma-A systematic review[J]. Surg Oncol, 2013, pii:S0960-7404(13)00027-3. doi:10.1016/j.suronc.2013.02.009.
|
26. |
Hu Z, Wang W, Li Z, et al. Recipient outcomes of salvage liver transplantation versus primary liver transplantation:a systematic review and meta-analysis[J]. Liver Transpl, 2012, 18(11):1316-1323.
|
27. |
Liu F, Yuan D, Wei YG, et al. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk[J]. Plos One, 2012, 7(8):1-10.
|
28. |
方河清, 唐酷, 何敏志. 射频消融在复发性肝癌治疗中的应用[J]. 肝胆外科杂志, 2012, 20(4):246-247.
|
29. |
区应亮, 孙建, 王慧玲, 等. 肝癌根治性切除术后早期复发的治疗策略[J]. 广东医学, 2012, 33(5):622-625.
|